E. coli neo, mouse H-ras genomic DNA, Phage P1 cre, E. coli lacZ Triple mutant mice having a Kras gene knockout, cre and lacZ transgene. 笹岡　俊邦 Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> B6.Cg-Hras1<tm1Mok> Tg(cre) Tg(lacZ) B6.Cg-Hras1<tm1Mok> Tg(cre) Tg(lacZ) D（6か月以上） In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Oncogene, 19, 2951-2956 (2000).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to Dr. Motoya Katsuki is requested. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. true RBRC02460 H-ras-KO, Cre, LacZTg, B6-Hras KO/Cre lacZ Tg H-ras-KO, Cre, LacZTg, B6-Hras KO/Cre lacZ Tg 基礎生物学研究所・勝木元也。 Toshikuni SASAOKA 条件を付加する。<br>研究成果の公表にあたって寄託者の指定する文献を引用する。Oncogene, 19, 2951-2956 (2000).<br>利用者は、研究成果の公表にあたって、勝木元也博士へ謝辞の表明を必要とする。利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び事業活動を行う場合は、寄託者と別途協議を行う。 D (more than 6 months) Developed by Motoya Katsuki, National Institutes of Natural Sciences. CCE/EK.CCE [129S/SvEv-Gpi1<c>] Hras遺伝子のノックアウト、cre TgならびにlacZ Tgトリプルミュータントマウス。